Abnormal adipose tissue morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal behavior
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
TREM2 expression in leukocytes may be a novel biomarker for neurological and psychiatric disorders.
|
26332043 |
2015 |
Abnormal brain FDG positron emission tomography
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal lower motor neuron morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal social behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of epiphysis morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of vision
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abulia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
|
28714976 |
2017 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Evidence of trem2 variant associated with triple risk of Alzheimer's disease.
|
24663666 |
2014 |
Acute leukemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adrenomyeloneuropathy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Within the spinal cord of humans and mice with AMN, upregulation of several phagocytosis-related markers, such as MFGE8 and TREM2, precedes complement activation and synapse loss.
|
29059709 |
2017 |
Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In living human microglia CHME-5 and glioblastoma T98G cells, activation of TREM2 by its specific antibody induced [Ca2+]i responses, documenting its surface expression and functioning.
|
15548205 |
2004 |
Age related macular degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we report a significant deficit in TREM2 in AMD retina and in cytokine- or oxidatively-stressed microglial (MG) cells.
|
26949937 |
2016 |
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Agitation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Agitation, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Agitation, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Agnosia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Alexia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Alzheimer Disease, Early Onset
|
0.330 |
Biomarker
|
disease |
CTD_human |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
|
28714976 |
2017 |
Alzheimer Disease, Early Onset
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
|
23380991 |
2013 |
Alzheimer Disease, Early Onset
|
0.330 |
Biomarker
|
disease |
BEFREE |
Furthermore, this study identified shared risk genes between EOAD and LOAD similar to previously reported genes, such as SORL1, PSEN2, and TREM2.
|
28738127 |
2017 |
Alzheimer Disease, Early Onset
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
|
25160042 |
2014 |
Alzheimer Disease, Early Onset
|
0.330 |
Biomarker
|
disease |
CTD_human |
Evidence of trem2 variant associated with triple risk of Alzheimer's disease.
|
24663666 |
2014 |